Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Infanrix Hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) |
| BNF code | 1404000F0BQAAAZ |
| Virtual Medicinal Product | Diphtheria / Tetanus / Pertussis (acellular component) / Hepatitis B (surface antigen) / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) powder and suspension for suspension for injection 0.5ml pre-filled syringes |
| Name | Infanrix Hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes |
| Abbreviated name | Infanrix Hexa vacc inj 0.5ml pre-filled syringes |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Infanrix Hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.